Page 22 - Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Group Today - Breaking & Trending Today

$SELLAS Life Sciences Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients Relapsed/Refractory to Venetoclax in Ongoing Phase 1 Study - Vimarsana News$

SELLAS Life Sciences Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients Relapsed/Refractory to Venetoclax in Ongoing Phase 1 Study

Published: April 11, 2022

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the first acute myeloid leukemia (AML) patient has enrolled in the fifth dose level (22.

Source: pressreleasepoint.com

Related Topics:

Mid-Morning Market Update: Markets Higher; US Economy Adds 431,000 Jobs In March

Published: April 1, 2022

U.S. stocks opened higher this morning following the release of non-farm payroll data for March. The Dow traded up 0.17% to 34,735.64 while the N...

Source: businessinsider.com

Related Topics:

United States City Of United Kingdom Chicken Soup For The Soul Entertainment Inc Tellurian Inc Borr Drilling Limited Blackboxstocks Inc Life Sciences Group Inc Redwire Corporation Didi Global Inc Alphabet And Stocks Sold By Insiders Chicken Soup Soul Entertainment Sciences Group Executives Buy More Than Baker Hughes North American

SELLAS Life Sciences Announces Proposed Underwritten Public Offering

Published: April 1, 2022

SELLAS Life Sciences Group, Inc.

Source: pressreleasepoint.com

SELLAS Life Sciences Announces Pricing of $25.0 Million

Published: April 1, 2022

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical...

Source: globenewswire.com

Related Topics:

New York United States Memorial Sloan Kettering Cancer Center Raquel Cona Michaela Fawcett Allison Soss Cantor Fitzgerald Co Genfleet Therapeutics Shanghai Inc Exchange Commission Life Sciences Group Inc Strategic Communications Syndicate Department Sciences Group Cantor Fitzgerald Capital Markets Genfleet Therapeutics Annual Report Nasdaq Sls Sellas Life Sciences Group

SELLAS Life Sciences Announces Pricing of $25.0 Million Underwritten Public Offering - Press Release

Published: April 1, 2022

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. SLS ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical

Source: wiredprnews.com

Related Topics:

New York United States Memorial Sloan Kettering Cancer Center Raquel Cona Michaela Fawcett Allison Soss Exchange Commission Strategic Communications Life Sciences Group Inc Cantor Fitzgerald Co Syndicate Department Genfleet Therapeutics Shanghai Inc Sciences Group Cantor Fitzgerald Capital Markets Genfleet Therapeutics Annual Report

Page 23 Page 24 Page 25 Page 26